We provide innovative chromosome engineering technology widely for medical and drug development! Contributing to life and health!
TransChromosomics Co., Ltd. is a bio-venture originating from Tottori University, established with the aim of developing drug discovery and drug discovery support tools, based on the know-how of chromosome engineering technology acquired by CEO Mitsuo Oshimura during his 30 years of research. Using cutting-edge chromosome engineering technology, we conduct chromosome modifications, iPS/ES cell production, genetically modified mouse and rat production, animal testing, antibody production, and more. 【Business Activities】 ■ Development of fully human antibody-producing rats ■ Development of genetic rare disease model animals and cell transplantation therapy ■ Development of human-like drug metabolism model animals ■ Contract testing For contract testing inquiries or questions, please use the contact form. You can also reach us through our official website. http://trans-chromo.wix.com/trans-chromosomics *For more details, please refer to our catalog or feel free to contact us.
Inquire About This Product
basic information
【Business Items】 ■ Development of fully human antibody-producing rats - Research is conducted in collaboration with the Chromosome Engineering Research Center at Tottori University. * Supported by the Ministry of Education, Culture, Sports, Science and Technology's Innovative Biopharmaceutical Extraction Infrastructure Technology Development Project. ■ Development of genetic rare disease model animals and cell transplantation therapy - We create model animals that help elucidate the mechanisms of diseases such as Down syndrome and muscular dystrophy, and assist in new drug development. ■ Development of human-like drug metabolism model animals - We produce human-like drug metabolism model mice and rats equipped with artificial chromosome vectors containing human drug metabolism-related genes, allowing for the prediction of safety for humans when new drugs are administered, leading to accelerated pharmaceutical development and cost reduction. ■ Contract testing - Karyotype analysis - FISH analysis - Multicolor FISH analysis, etc. For contract testing or inquiries, please use the contact form. You can also inquire through the official website. http://trans-chromo.wix.com/trans-chromosomics * For more details, please refer to the catalog or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the catalog or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
TransChromosomics Co., Ltd. is a Tottori University-based biotech venture established with the aim of developing drug discovery and drug discovery support tools, leveraging the know-how of chromosome engineering technology acquired by CEO Mitsuo Oshimura during his 30 years of research. Using cutting-edge chromosome engineering technology, the company conducts chromosome modification, iPS/ES cell production, genetically modified mouse and rat production, animal testing, and antibody production, among other activities.